Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Arimoclomol & Ipique Developers To Make Their Case For EU Approval
Orphazyme & Rotterdam Biologics Are Scheduled To Present Before The EMA This Week
Feb 22 2022
•
By
Neena Brizmohun
EU approval is being sought for an ophthalmic bevacizumab drug • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Europe
More from Geography